CHDI
Listed here are over 1,045 publications that describe some of the research funded (in whole or in part) by CHDI Foundation. You can also view just the subset of publications that have CHDI staff as authors.
Publication Search
Title
Journal
Dawson J, Baine-Savanhu FK, Ciosi M, Maxwell A, Monckton DG, Krause A
A probable cis-acting genetic modifier of Huntington disease frequent in individuals with African ancestry
Reasoner EE, van der Plas E, Al-Kaylani HM, Langbehn DR, Conrad AL, Schultz JL, Epping EA, Magnotta VA, Nopoulos PC
Behavioral features in child and adolescent huntingtin gene-mutation carriers
Byrne LM, Schultz JL, Rodrigues FB, van der Plas E, Langbehn D, Nopoulos PC, Wild EJ
Neurofilament light protein as a potential blood biomarker for Huntington's disease in children
Tabrizi SJ, Estevez-Fraga C, van Roon-Mom WMC, Flower MD, Scahill RI, Wild EJ, Muñoz-Sanjuan I, Sampaio C, Rosser AE, Leavitt BR
Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities
Tabrizi SJ, Schobel S, Gantman EC, Mansbach A, Borowsky B, Konstantinova P, Mestre TA, Panagoulias J, Ross CA, Zauderer M, Mullin AP, Romero K, Sivakumaran S, Turner EC, Long JD, Sampaio C, Huntington’s Disease Regulatory Science Consortium (HD-RSC)
A biological classification of Huntington's disease: the Integrated Staging System
Nazarov S, Chiki A, Boudeffa D, Lashuel HA
Structural basis of huntingtin fibril polymorphism revealed by cryogenic electron microscopy of exon 1 HTT fibrils
Medaglia JD, Erickson BA, Pustina D, Kelkar AS, DeMarco AT, Dickens JV, Turkeltaub PE
Simulated attack reveals how lesions affect network properties in poststroke aphasia
Warner JH, Long JD, Mills JA, Langbehn DR, Ware J, Mohan A, Sampaio C
Standardizing the CAP score in Huntington's disease by predicting age-at-onset
Reasoner EE, van der Plas E, Langbehn DR, Conrad AL, Koscik TR, Epping EA, Magnotta VA, Nopoulos PC
Cortical features in child and adolescent carriers of mutant huntingtin (mHTT)
J Huntingtons Dis
June 3, 2022
11 (2) :173-178
11 (2) :173-178
PMID: 35275555
PMCID: 9177765
DOI: 10.3233/JHD-210512
Turner EC, Gantman EC, Sampaio C, Sivakumaran S
Huntington's Disease Regulatory Science Consortium: accelerating medical product development
Exuzides A, To TM, Abbass IM, Ta JT, Patel AM, Surinach A, Fuller RLM, Luo J
Healthcare resource utilization and costs in individuals with Huntington's disease by disease stage in a US population
Rosser AE, Busse ME, Gray WP, Aron Badin R, Perrier AL, Wheelock V, Cozzi E, Perpiña Martin U, Salado-Manzano C, Mills LJ, Drew C, Goldman SA, Canals JM, Thompson LM
Translating cell therapies for neurodegenerative diseases: Huntington's disease as a model disorder
Bertoglio D, Verhaeghe J, Wyffels L, Miranda A, Stroobants S, Mrzljak L, Dominguez C, Skinbjerg M, Bard J, Liu L, Munoz-Sanjuan I, Staelens S
Synaptic vesicle glycoprotein 2A is affected in the CNS of Huntington's Disease mice and post-mortem human HD brain
Shin JW, Shin A, Park SS, Lee JM
Haplotype-specific insertion-deletion variations for allele-specific targeting in Huntington's disease
Tan B, Shishegar R, Fornito A, Poudel G, Georgiou-Karistianis N
Longitudinal mapping of cortical surface changes in Huntington's disease
Lee JM, Huang Y, Orth M, Gillis T, Siciliano J, Hong E, Mysore JS, Lucente D, Wheeler VC, Seong IS, McLean ZL, Mills JA, McAllister B, Lobanov SV, Massey TH, Ciosi M, Landwehrmeyer GB, Paulsen JS, Dorsey ER, Shoulson I, Sampaio C, Monckton DG, Kwak S, Holmans P, Jones L, MacDonald ME, Long JD, Gusella JF
Genetic modifiers of Huntington disease differentially influence motor and cognitive domains
Barbé L, Finkbeiner S
Genetic and epigenetic interplay define disease onset and severity in repeat diseases
Langbehn DR, Fine EM, Meier A, Hersch S
Utility of the Huntington's disease prognostic index score for a perimanifest clinical trial
Nair A, Razi A, Gregory S, Rutledge RB, Rees G, Tabrizi SJ
Imbalanced basal ganglia connectivity is associated with motor deficits and apathy in Huntington's disease
Piccolo FM, Kastan NR, Haremaki T, Tian Q, Laundos TL, De Santis R, Beaudoin AJ, Carroll TS, Luo JD, Gnedeva K, Etoc F, Hudspeth AJ, Brivanlou AH
Role of YAP in early ectodermal specification and a Huntington's Disease model of human neurulation
Greco TM, Secker C, Ramos ES, Federspiel JD, Liu JP, Perez AM, Al-Ramahi I, Cantle JP, Carroll JB, Botas J, Zeitlin SO, Wanker EE, Cristea IM
Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease
Fischer DF, Dijkstra S, Lo K, Suijker J, Correia ACP, Naud P, Poirier M, Tessari MA, Boogaard I, Flynn G, Visser M, Lamers MBAC, McAllister G, Munoz-Sanjuan I, Macdonald D
Development of mAb-based polyglutamine-dependent and polyglutamine length-independent huntingtin quantification assays with cross-site validation
Gu X, Richman J, Langfelder P, Wang N, Zhang S, Bañez-Coronel M, Wang HB, Yang L, Ramanathan L, Deng L, Park CS, Choi CR, Cantle JP, Gao F, Gray M, Coppola G, Bates GP, Ranum LPW, Horvath S, Colwell CS, Yang XW
Uninterrupted CAG repeat drives striatum-selective transcriptionopathy and nuclear pathogenesis in human Huntingtin BAC mice
McAllister B, Donaldson J, Binda CS, Powell S, Chughtai U, Edwards G, Stone J, Lobanov S, Elliston L, Schuhmacher LN, Rees E, Menzies G, Ciosi M, Maxwell A, Chao MJ, Hong EP, Lucente D, Wheeler V, Lee JM, MacDonald ME, Long JD, Aylward EH, Landwehrmeyer GB, Rosser AE, REGISTRY Investigators of EHDN, Paulsen JS, PREDICT-HD Investigators of HSG, Williams NM, Gusella JF, Monckton DG, Allen ND, Holmans P, Jones L, Massey TH
Exome sequencing of individuals with Huntington's disease implicates FAN1 nuclease activity in slowing CAG expansion and disease onset
Bertoglio D, Verhaeghe J, Miranda A, Wyffels L, Stroobants S, Mrzljak L, Khetarpal V, Skinbjerg M, Liu L, Dominguez C, Munoz-Sanjuan I, Bard J, Staelens S
Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington's disease
Ramírez-Jarquín UN, Sharma M, Shahani N, Li Y, Boregowda S, Subramaniam S
Rhes protein transits from neuron to neuron and facilitates mutant huntingtin spreading in the brain
Mohan A, Sun Z, Ghosh S, Li Y, Sathe S, Hu J, Sampaio C
A machine-learning derived Huntington's disease progression model: Insights for clinical trial design
Callahan JW, Wokosin DL, Bevan MD
Dysregulation of the basal ganglia indirect pathway in early symptomatic Q175 Huntington's disease mice
Rodrigues FB, Owen G, Sathe S, Pak E, Kaur D, Ehrhardt AG, Lifer S, Townhill J, Schubert K, Leavitt BR, Guttman M, Bang J, Lewerenz J, Levey J, HDClarity Investigators, Sampaio C, Wild EJ
Safety and feasibility of research lumbar puncture in Huntington's disease: The HDClarity cohort and bioresource
Bertoglio D, Bard J, Hessmann M, Liu L, Gärtner A, De Lombaerde S, Huscher B, Zajicek F, Miranda A, Peters F, Herrmann F, Schaertl S, Vasilkovska T, Brown CJ, Johnson PD, Prime ME, Mills MR, Van der Linden A, Mrzljak L, Khetarpal V, Wang Y, Marchionini DM, Skinbjerg M, Verhaeghe J, Dominguez C, Staelens S, Munoz-Sanjuan I
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease
Ramírez-Jarquín UN, Sharma M, Zhou W, Shahani N, Subramaniam S
Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease
Proc Natl Acad Sci USA
February 1, 2022
119 (5) :e2107187119
119 (5) :e2107187119
PMID: 35086928
Iennaco R, Formenti G, Trovesi C, Rossi RL, Zuccato C, Lischetti T, Bocchi VD, Scolz A, Martínez-Labarga C, Rickards O, Pacifico M, Crottini A, Møller AP, Chen RZ, Vogt TF, Pavesi G, Horner DS, Saino N, Cattaneo E
The evolutionary history of the polyQ tract in huntingtin sheds light on its functional pro-neural activities
Hirschberg S, Dvorzhak A, Rasooli-Nejad SMA, Angelov S, Kirchner M, Mertins P, Lättig-Tünnemann G, Harms C, Schmitz D, Grantyn R
Uncoupling the excitatory amino acid transporter 2 from its C-terminal interactome restores synaptic glutamate clearance at corticostriatal synapses and alleviates mutant huntingtin-induced hypokinesia
Fote GM, Geller NR, Efstathiou N, Hendricks N, Vavvas DG, Reidling JC, Thompson LM, Steffan JS
Isoform-dependent lysosomal degradation and internalization of Apolipoprotein E requires autophagy proteins
Oikemus SR, Pfister E, Sapp E, Chase KO, Kennington LA, Hudgens E, Miller R, Zhu LJ, Chaudhary A, Mick EO, Sena-Esteves M, Wolfe SA, DiFiglia M, Aronin N, Brodsky MH
Allele-specific knockdown of mutant HTT protein via editing at coding region SNP heterozygosities
Wang W, Zhou P, Wang X, Chen F, Christensen E, Thompson J, Ren X, Kells A, Stanek L, Carter T, Hou J, Sah DWY
Efficient and precise processing of the optimized primary artificial microRNA in a huntingtin-lowering adeno-associated viral gene therapy in vitro and in mice and nonhuman primates
Zeun P, McColgan P, Dhollander T, Gregory S, Johnson EB, Papoutsi M, Nair A, Scahill RI, Rees G, Tabrizi SJ, TrackOn-HD and HD-YAS Investigators
Timing of selective basal ganglia white matter loss in premanifest Huntington's disease
Ferreira JJ, Rodrigues FB, Duarte GS, Mestre TA, Bachoud-Levi AC, Bentivoglio AR, Burgunder JM, Cardoso F, Claassen DO, Landwehrmeyer GB, Kulisevsky J, Nirenberg MJ, Rosser A, Roth J, Seppi K, Slawek J, Furr-Stimming E, Tabrizi SJ, Walker FO, Vandenberghe W, Costa J, Sampaio C
A MDS evidence-based review on treatments for Huntington's disease
Pace JB, Huang NN, Séguin JP, Esquina C, Olin E, Zhu G, Carr G
Efficient and scalable production of full-length human huntingtin variants in mammalian cells using a transient expression system
Harding RJ, Deme JC, Hevler JF, Tamara S, Lemak A, Cantle JP, Szewczyk MM, Begeja N, Goss S, Zuo X, Loppnau P, Seitova A, Hutchinson A, Fan L, Truant R, Schapira M, Carroll JB, Heck AJR, Lea SM, Arrowsmith CH
Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon